Synergism of imatinib, vatalanib and everolimus in the prevention of chronic lung allograft rejection after lung transplantation (LTx) in rats.

In conclusion, the combination of mTORI and RTKIs might be a possible strategy in the prevention of CLAD and BO. PMID: 30706940 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30706940?dopt=Abstract

Source: Histology and Histopathology - February 3, 2019 Category: Cytology Tags: Histol Histopathol Source Type: research